NEW YORK, Jan 23 – Phase-1 Molecular Toxicology, a privately held Santa Fe, N.M.–based toxicogenomics company, said Tuesday it has signed an agreement to sell Axon Instruments’ GenePx 4000B microarray scanner along with its toxicogenomic and toxicoproteomic microarrays and software.

The companies will offer the scanner, arrays, and software as a package deal, according to Phase-1 CEO Spencer Farr, who declined to specify how the companies will share revenues.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The United Nations is to consider a ban on field testing gene drives at a meeting being held next week, Technology Review reports.

The Associated Press reports that gene-edited food may soon be for sale.

The US Department of Health and Human Services is beginning a series of meetings on human fetal tissue research, Stat News reports.

In Cell this week: epigenetic change linked to glioblastomas, rare and low-frequency variants contributing to multiple sclerosis risk, and more.